| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000041843 |
| Receipt No. | R000047766 |
| Scientific Title | A study for the effect of microorganism containing foods on incident rate of infectious diseases in selected community. A randomized, double-blind, placebo-controlled, parallel-group comparison trial. |
| Date of disclosure of the study information | 2020/09/25 |
| Last modified on | 2022/04/21 (Ver. 4) |
| Basic information | ||
| Public title | A study for the effect of microorganism containing foods on incident rate of infectious diseases in selected community. A randomized, double-blind, placebo-controlled, parallel-group comparison trial.
|
|
| Acronym | A study for the effect of microorganism containing foods on infectious diseases | |
| Scientific Title | A study for the effect of microorganism containing foods on incident rate of infectious diseases in selected community. A randomized, double-blind, placebo-controlled, parallel-group comparison trial. | |
| Scientific Title:Acronym | A study for the effect of microorganism containing foods on infectious diseases | |
| Region |
|
|
| Condition | |||
| Condition | None(Healthy school children) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of microorganism containing foods on incident rate of infectious diseases. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The school absent rate of participants due to infectious diseases |
| Key secondary outcomes | 1. General wellbeing of participants evaluated by questionnaires.
2. Z-score as nutritional status of participants 3. Severity of infectious disease like illness |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Daily one bottle of study product including microorganism (beverage 280ml) is administered to participant for consecutive 8 weeks. | |
| Interventions/Control_2 | Daily one bottle of placebo (without microorganism, 280ml) is administered to participant for consecutive 8 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Provide signed and dated informed consent form after confirming the willingness of participants (guardians)
2. Willingness to comply with all study procedures for the period of the study (both participants and guardians) 3. Aged 6 to 9 years old (elementary school grades 1 to 3 equivalent) 4. Residing in selected community with Vietnam citizen (both participants and guardians) 5. No underlying chronic sickness of respiratory disease and/or gastrointestinal disease at enrollment (participants) |
|||
| Key exclusion criteria | 1. Unable to provide signed and dated informed consent form (guardians)
2. Unable to comply with all the study procedures (participants and guardians) 3. Allergic to milk (participants) 4. Regularly using steroid drugs (participants) 5. Person who has serious respiratory and/or gastrointestinal disease (participants) 6. Additionally, other persons whom the principal investigators deem inappropriate as participants for the study 7. Person who are currently participating in other clinical trials (participants) and who are planning to participate in other clinical trials during the trial period (participants) |
|||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Institute of Nutrition | ||||||
| Division name | National Institute of Nutrition | ||||||
| Zip code | - | ||||||
| Address | 48B Tang Bat Ho, Hanoi, Vietnam | ||||||
| TEL | +84-24-3971-3137 | ||||||
| truongmai1976@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kirin Holdings Co., Ltd. | ||||||
| Division name | Research & Development Strategy Department | ||||||
| Zip code | 1640001 | ||||||
| Address | 10-2, Nakano 4-Chome, Tokyo, 164-0001, Japan | ||||||
| TEL | 03-6837-7035 | ||||||
| Homepage URL | |||||||
| Yuta_Watanabe@kirin.co.jp | |||||||
| Sponsor | |
| Institute | National Institute of Nutrition |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kirin Holdings Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethical Committee of National Institute of Nutrition, Ministry of Health, Vietnam |
| Address | 48B Tang Bat Ho, Hanoi, Vietnam |
| Tel | +84 24 3971 3137 |
| truongtuyetmai@dinhduong.org.vn | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | Ninh Binh province commune health center |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.mdpi.com/2072-6643/14/3/552/htm |
| Publication of results | Published |
| Result | |
| URL related to results and publications | https://www.mdpi.com/2072-6643/14/3/552/htm |
| Number of participants that the trial has enrolled | 1109 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047766 |